Haematologic effects of delayed 16 h administration of leucovorin (LV) following high-dose methotrexate (HDMTX) were analyzed in C57B1×C3HF1 mice. Results show that 16 h administration of LV significantly reduces the toxic effects of HDMTX on hemopoietic progenitors and bone marrow cells. At 12 days after HDMTX administration, the bone marrow level of CFUs was significantly higher in HDMTX-LV treated mice than in HDMTX treated animals. In comparison with previous data obtained when LV was injected 2 h after HDMTX, the delay in administration of LV does not appear to reduce the protective effect of the vitamin.
Get full access to this article
View all access options for this article.
References
1.
BertinoJ.R.: «Rescue» techniques in cancer chemotherapy: Use of leucovorin and other rescue agents after methotrexate treatment.Semin. Oncol., 4: 203–216, 1977.
2.
ChabnerB.A., MayersC.E.: Antimetabolites. In: Cancer, Principles and Practice of Oncology, pp. 156–172, de VitaV.T.Jr., HellmanS., & RosenbergS.A. (Eds.), Lippincott, Philadelphia, Toronto, 1981.
3.
PannacciulliI., MassaG., BoglioloG., GhioR., SobreroA.: Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.Cancer Res., 42: 530–534, 1982.
4.
PinedoH.M., ChabnerB.A., ZaharkoD.S., BullJ.M.: Evidence for recruitment of granulocyte precursor during high-dose methotrexate infusion in mice.Blood, 48: 301–307, 1976.
5.
PinedoH.M., ZaharkoD.S., BullJ., ChabnerB.A.: The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.Cancer Res., 37: 445–450, 1977.
6.
SirotnakF.M., DorsbackR.C., MoccioD.M., DorikD.M.: Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine model.Cancer Res., 36: 4679–4686, 1976.
7.
SirotnakF.M., DorsbackR.C., DorikD.M., MoccioD.M.: High-dose methotrexate therapy with citrovorum factor: A pharmacologic perspective in murine tumor models.Cancer Treat. Rep., 61: 565–574, 1977.
8.
SirotnakF.M., MoccioD.M., DorikD.M.: Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma-180 murine tumor models.Cancer Res., 38: 345–353, 1978.
9.
TillJ.E., McCullochE.A.: A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.Radiat. Res., 14: 213–222, 1961.
